Does dasatinib require long-term continued use?

There is no absolute answer to the question of whether dasatinib needs to be used for a long time, but depends on the patient's specific situation and treatment effect.

The treatment duration of dasatinib tablets is generally about 2 years, but this is only a rough time range. The actual length of treatment depends on the patient's sensitivity and tolerance to the drug, as well as the presence of comorbidities, among other factors. If the patient responds well to the drug, has no adverse reactions, and the disease progresses slowly, he may need to continue using dasatinib tablets for about 2 years. However, if the patient is sicker or does not respond well to the medication, treatment may be longer.

During the use of dasatinib tablets, doctors will adjust the treatment plan based on the patient's disease progression and treatment effect. If the patient's condition is controlled during treatment and no serious adverse reactions occur, treatment can continue according to the original plan. However, if the condition recurs or worsens, or if the patient experiences serious adverse reactions, the doctor may consider adjusting the dose or changing the treatment regimen.

Although dasatinib tablets have good efficacy in the treatment of chronic myelogenous leukemia, it does not need to be taken for life. Once the patient's condition is effectively controlled and there are no signs of recurrence or progression, the dose can be gradually reduced and eventually discontinued under the guidance of a doctor. Of course, regular follow-up and monitoring are still required after stopping the drug to ensure the stability of the condition.

When deciding whether to continue or stop using dasatinib tablets, doctors will also comprehensively consider the patient's overall condition, including age, physical condition, comorbidities and other factors. For older patients or those with severe comorbidities, physicians may be more cautious in assessing the risks and benefits of treatment and making decisions accordingly.